Suven Life Sciences Ltd (NSE:SUVEN) Share Price

Company Profile

Business description
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.
Contact
Avenue 7, Road No. 5, Banjara Hills
Number 8-2-334, 6th Floor, SDE Serene Chambers
HyderabadTG500 034
IND
T: +91 4023541142
https://www.suven.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
141

Recommended

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Malik Ahmed Khan, CFA | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,999.00	16.40	-0.18%
CAC 40	7,878.10	16.14	0.21%
DAX 40	24,395.74	133.52	0.55%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,166.43	29.49	0.32%
HKSE	24,773.33	403.60	-1.60%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	41,069.82	415.12	1.02%
NZX 50 Index	12,823.74	32.23	-0.25%
S&P 500	6,362.90	7.96	-0.12%
S&P/ASX 200	8,742.80	13.60	-0.16%
SSE Composite Index	3,573.21	42.51	-1.18%